Inovio Pharmaceuticals, Inc.
INO
$1.31
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.87% | -44.88% | -37.83% | -40.09% | -56.94% |
| Total Receivables | -- | -- | -99.96% | -47.46% | -52.62% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -24.80% | -20.86% | 3.69% | -26.39% | -19.73% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.26% | -45.14% | -37.52% | -39.55% | -55.17% |
|
|
|||||
| Total Current Assets | -24.26% | -45.14% | -37.52% | -39.55% | -55.17% |
| Net Property, Plant & Equipment | -27.63% | -24.93% | -22.96% | -22.82% | -21.64% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.74% | 1.66% | 1.66% | 255.31% | 243.49% |
| Total Assets | -27.62% | -42.96% | -34.35% | -35.19% | -49.00% |
|
|
|||||
| Total Accounts Payable | -33.62% | -64.01% | -59.35% | 9.62% | -14.44% |
| Total Accrued Expenses | -31.25% | -16.40% | -30.24% | -31.44% | -31.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.13% | 12.92% | 13.02% | 12.92% | 14.39% |
| Total Finance Division Other Current Liabilities | 119.13% | 161.25% | 119.29% | -- | 52,047.49% |
| Total Other Current Liabilities | 119.13% | 161.25% | 119.29% | -- | 52,047.49% |
| Total Current Liabilities | 25.88% | 38.78% | 23.62% | 197.13% | 20.11% |
|
|
|||||
| Total Current Liabilities | 25.88% | 38.78% | 23.62% | 197.13% | 20.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -36.22% | -33.45% | -30.13% | -27.33% | -24.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.37% | 21.34% | 12.35% | 130.03% | 7.16% |
|
|
|||||
| Common Stock & APIC | 2.38% | 2.20% | 2.25% | 1.50% | 1.10% |
| Retained Earnings | -3.80% | -4.85% | -4.91% | -6.32% | -5.21% |
| Treasury Stock & Other | 57.68% | 3.81% | 5.58% | -3.83% | 4.03% |
| Total Common Equity | -84.68% | -88.16% | -64.82% | -110.50% | -70.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -84.68% | -88.16% | -64.82% | -110.50% | -70.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -84.68% | -88.16% | -64.82% | -110.50% | -70.51% |
|
|
|||||